Flublok for Patients with Severe Egg Allergy
Flublok (recombinant influenza vaccine) is the preferred option for adults ≥18 years with severe egg allergy because it is completely egg-free and carries no contraindication for egg allergy of any severity. 1, 2
Key Characteristics of Flublok
Flublok is manufactured without using eggs or influenza viruses, utilizing instead a recombinant hemagglutinin (HA) production process in insect cell culture with baculovirus expression technology. 1 This manufacturing process fundamentally distinguishes it from traditional egg-based vaccines and makes it truly egg-free. 2
Available Formulations and Dosing
- Trivalent formulation (RIV3/Flublok): Originally approved for ages 18-49 years, contains 135 μg total HA (45 μg per strain). 1
- Quadrivalent formulation (RIV4/Flublok Quadrivalent): Approved for ages ≥18 years, contains 180 μg total HA (45 μg per strain). 2, 3
- Administration: 0.5 mL intramuscular injection. 1
Specific Recommendations for Egg-Allergic Patients
For Severe Egg Allergy (Beyond Hives)
Flublok can be administered to persons with egg allergy of any severity who are aged ≥18 years without special precautions beyond standard vaccination protocols. 1, 3 This includes patients with:
- Angioedema after egg exposure
- Respiratory distress after egg exposure
- Recurrent emesis requiring epinephrine
- Any severe systemic reaction to eggs 4, 5
For Mild Egg Allergy (Hives Only)
While Flublok is an excellent option, any age-appropriate influenza vaccine can be safely administered to patients with only hives after egg exposure without special precautions. 3, 4 However, Flublok remains preferred when available for those who prefer complete avoidance of egg protein. 1
Clinical Evidence Supporting Safety and Efficacy
Immunogenicity and Effectiveness
In a placebo-controlled efficacy trial, Flublok demonstrated 75.4% vaccine effectiveness against matched influenza strains and 44.6% effectiveness regardless of match. 1 The higher antigen content (45 μg HA per strain versus 15 μg in standard vaccines) results in improved immunogenicity compared to traditional vaccines. 6
Safety Profile
The most common adverse reactions are mild injection site pain (>37%), headache (>15%), fatigue (>15%), and myalgias (>11%). 1 Importantly, 94% of pain reports were rated as mild. 1
Postmarketing surveillance through VAERS identified 849 reports after RIV4 vaccination, with 95% being non-serious. 7 While allergic reactions were reported, these may reflect underlying atopy rather than vaccine-specific allergenicity, and the vaccine remains safe for egg-allergic individuals. 7
Contraindications and Precautions
The only contraindication to Flublok is a previous severe allergic reaction to any component of the vaccine itself. 1, 2 This is distinct from egg allergy, which is NOT a contraindication. 1
General Precautions (Not Specific to Egg Allergy)
- Moderate or severe acute illness with or without fever 1, 2
- Guillain-Barré syndrome within 6 weeks of a previous influenza vaccine dose 1, 2
Critical Clinical Pitfalls to Avoid
Do not delay vaccination in egg-allergic patients waiting for Flublok if other age-appropriate vaccines are available, as any licensed influenza vaccine can be safely administered to egg-allergic individuals. 1, 3
Do not perform skin testing before administering Flublok or any influenza vaccine to egg-allergic patients, as this is no longer recommended. 3, 4
Do not use divided-dose protocols, as these are outdated and unnecessary. 4, 5
Ensure all vaccination providers are familiar with office emergency plans and certified in CPR, as required for all vaccine administration. 3, 5
Comparison with Other Egg-Free/Low-Egg Options
Cell culture-based vaccine (ccIIV/Flucelvax) contains theoretical trace egg protein (5×10⁻⁸ μg per dose) from seed virus passage in eggs, making it essentially but not completely egg-free. 1, 3 Flublok is the only truly egg-free influenza vaccine option. 2, 3